Results 231 to 240 of about 35,727 (262)

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST) [PDF]

Clinical Microbiology and Infection, 2012
The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has revised the EDef 7.1 document on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for fermentative yeasts.
Cornelia Lass-Flörl, William Hope
exaly   +5 more sources

EUCAST technical note on posaconazole* [PDF]

Clinical Microbiology and Infection, 2011
The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has determined breakpoints for posaconazole for Candida spp. This Technical Note is based on the EUCAST posaconazole rationale document (available on the EUCAST website: http://www.eucast.org).
Arendrup, M.C., Cuenca-Estrella, M., Donnelly, J.P., Hope, W., Lass-Florl, C., Rodriguez-Tudela, J.L.   +5 more
exaly   +4 more sources

EUCAST technical note on anidulafungin [PDF]

Clinical Microbiology and Infection, 2011
The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing has determined breakpoints for anidulafungin for Candida spp. This Technical Note is based on the EUCAST anidulafungin rationale document (available at: http://www.eucast.org). Species-specific breakpoints for C.
Arendrup, M.C., Rodriguez-Tudela, J.L., Lass-Florl, C., Cuenca-Estrella, M., Donnelly, J.P., Hope, W.   +5 more
exaly   +4 more sources

EUCAST expert rules in antimicrobial susceptibility testing [PDF]

Clinical Microbiology and Infection, 2013
EUCAST expert rules have been developed to assist clinical microbiologists and describe actions to be taken in response to specific antimicrobial susceptibility test results. They include recommendations on reporting, such as inferring susceptibility to other agents from results with one, suppression of results that may be inappropriate, and editing of
Leclercq, R., Cantón, R., Brown, D. F. J., Giske, C. G., Heisig, P., Macgowan, A. P., Mouton, J. W., Nordmann, P., Rodloff, A. C., ROSSOLINI, GIAN MARIA, Soussy, C. J., Steinbakk, M., Winstanley, T. G., Kahlmeter, G.   +13 more
exaly   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

EUCAST breakpoints for antifungals

Drug News & Perspectives, 2010
Susceptibility testing of fungi and development of interpretative breakpoints has become increasingly important due to the growing incidence of invasive fungal infections, the number and classes of antifungals, and the emerging reports of acquired resistance.
Rodriguez-Tudela, J.L., Arendrup, M.C., Cuenca-Estrella, M., Donnelly, J.P., Lass-Florl, C.   +4 more
openaire   +3 more sources

Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Journal of Clinical Microbiology, 2022
The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is an international susceptibility testing committee, organized by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) and functioning as the breakpoint advisory committee of the European Medicines Agency (EMA).
Christian G. Giske, John Turnidge, Rafael Cantón, Gunnar Kahlmeter   +3 more
openaire   +2 more sources

Temocillin disc diffusion susceptibility testing by EUCAST methodology

Journal of Antimicrobial Chemotherapy, 2013
Temocillin is a semi-synthetic b-lactam antibiotic which is the 6-a-methoxy derivative of ticarcillin. It is a narrow-spectrum agent and its activity is almost exclusively limited to the Enterobacteriaceae—it is not effective against Gram-positive organisms, anaerobes or Pseudomonas aeruginosa.
Gemma L, Vanstone, Rachel, Dilley, Stefan, Schwenk, Alan, Williams, Indran, Balakrishnan   +4 more
openaire   +2 more sources

Het bepalen van EUCAST klinische breekpunten

Nederlands Tijdschrift voor Medische Microbiologie, 2021
Breekpunten van de EUCAST worden in Nederland veel gebruikt. Deze worden vastgesteld aan de hand van een vaste procedure. Hierin worden verschillende facetten van zowel het pathogeen als de antibiotische behandeling geanalyseerd. De spreiding in ‘Minimum Inhibitory concentrations’ (MIC´s) van het pathogeen wordt bepaald met de bijbehorende ...
Yusuf, Erlangga, Muller, Anouk
openaire   +1 more source

De rationale documenten van de EUCAST

Nederlands Tijdschrift voor Medische Microbiologie, 2021
In Nederland worden veelal de breekpunten van de EUCAST gebruikt. Deze breekpunten zijn gebaseerdop farmacokinetische gegevens van een gemiddelde patiënt. De gegevens waarop deze breekpuntengebaseerd zijn, zijn beschreven in de zogeheten rationale documenten, die toegankelijk zijn via deEUCAST-website. In deze documenten staan gegevens die ook gebruikt
Verkaik, Nelianne, Muller, Anouk
openaire   +1 more source

From CLSI to EUCAST, a necessary step in Spanish laboratories

Enfermedades infecciosas y microbiologia clinica (English ed.), 2020
The Spanish Antibiogram Committee (Comité Español del Antibiograma, COESANT) presents in this document a simple "roadmap" or decalogue of recommendations, with a view to facilitating the transition from the Clinical and Laboratory Standards Institute (CLSI) to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) antimicrobial ...
María Nieves, Larrosa, Natividad, Benito, Rafael, Cantón, Andrés, Canut, Emilia, Cercenado, Felipe, Fernández-Cuenca, Jesús, Guinea, Antonio, López-Navas, Miguel Ángel, Moreno, Antonio, Oliver, Luis, Martínez-Martínez   +10 more
openaire   +2 more sources